Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Raised to $16 at Mizuho Securities on Announced Major Cost Cuts

November 29, 2017 6:45 AM
Mizuho Securities raised its price target on Teva Pharma (NYSE: TEVA) to $16.00 (from $12.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles